New & Novel Anticoagulants Hamid Al-Mondhiry, MD Professor of Medicine The Pennsylvania State University College of Medicine Hershey, PA VTE: Incidence and Impact in…

Estratificación de riesgo en FA: Sangrado vs. Embolismo Nuevos aspectos Adrian Baranchuk MD FACC Associate Professor of Medicine Heart Rhythm Service Queen’s University…

Antiphospholipid Syndrome Challenges in the Laboratory Diagnosis and Treatment A/Prof P Kuperan FRCP, FRCPA, FRCPath Head & Senior Consultant Department of Haematology…

Adverse Drug Reaction MUHAMMAD FAISAL NADEEM Introduction Defn: “an unwanted or harmful reaction experienced following the administration of a drug or combination of drugs…

PL Detail-Document #271001 −This PL Detail-Document gives subscribers additional insight related to the Recommendations published in− PHARMACIST’S LETTER / PRESCRIBER’S…

Medication Management and the Joint Commission: A 2009 Survey Experience Jennifer Davis, PharmD, BCPS, MBA Exempla Lutheran Medical Center Denver, Colorado April 2009 Objectives…

MCQ12/2555 1. กาหนดค่า Q=80% เม็ดยา warfarin 5 mg นามา 6 เม็ด N1=4.5, N2=4.5, ่ N3=5.25, N4=4.75, N5=5.25, N6=4.0 จะสรุ…

Apixaban versus Warfarin in Patients with Atrial Fibrillation Results of the ARISTOTLE Trial Presented on behalf of the ARISTOTLE Investigators and Committees Sponsored by…

1 ยาที่มีผลตอระบบเลื อด; ยาตานการแข็งตัวของเลือด ยาละลายลิ่มเลือด…

1. The Healthcare Team as the Health Care Provider A Different Perspective on the Patient Centered Medical Home James Dom Dera, MD, FAAFP 23 April 2010 2. Objectives Describe…